Content area
Full Text
In a prospective study involving 6 patients, a 51-year-old man was described ,who experienced ALT flare during treatment with lamivudine for hepatitis B virus (HBV)-related cirrhosis and a 50-year-old man was described, who showed development of resistance during treatment with adefovir dipivoxil and lamivudine for HBV-related cirrhosis.
Patient 1: A 51-year-old man experienced ALT flare during treatment with lamivudine for HBV-related cirrhosis. The man, who had HBV-related cirrhosis was receiving standard combination therapy with adefovir dipivoxil 10mg and lamivudine 100mg daily, tablet. He had underlying adefovir dipivoxil resistant mutation....